the aims of this article are to provide an overview of the current status of our research efforts and to provide an overview of the current status of the pharmacological and clinical data available on the aforementioned issues. we will also provide an overview of the current status of the clinical trial and the current status of the clinical trial. we will also provide a discussion of the current status of the clinical trial and its potential for the development of a new combination therapy for chronic hepatitis b.